Pheochromocytoma

Pheochromocytoma

Endocrine

Endocrine

Endocrine system anatomy and physiology
Growth hormone and somatostatin
Acromegaly
Gigantism
Constitutional growth delay
Hypoprolactinemia
Pituitary gland histology
Pituitary apoplexy
Pituitary adenoma
Pituitary adenomas and pituitary hyperfunction: Clinical
Pituitary tumors: Pathology review
Hyperpituitarism
Hypopituitarism
Hypopituitarism: Pathology review
Sheehan syndrome
Kallmann syndrome
Cortisol
Glucocorticoids
Adrenocorticotropic hormone
Synthesis of adrenocortical hormones
Adrenal hormone synthesis inhibitors
Cushing syndrome
Cushing syndrome: Clinical
Cushing syndrome and Cushing disease: Pathology review
Primary adrenal insufficiency
Adrenal insufficiency: Clinical
Adrenal insufficiency: Pathology review
Congenital adrenal hyperplasia
Congenital adrenal hyperplasia: Clinical
Adrenal masses and tumors: Clinical
Pheochromocytoma
Waterhouse-Friderichsen syndrome
Anatomy of the thyroid and parathyroid glands
Thyroid hormones
Hyperthyroidism
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Graves disease
Toxic multinodular goiter
Thyroid storm
Hyperthyroidism medications
Hypothyroidism
Hypothyroidism: Pathology review
Hypothyroidism and thyroiditis: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Riedel thyroiditis
Hypothyroidism medications
Thyroid cancer
Multiple endocrine neoplasia
Infertility: Clinical
Hyperaldosteronism
Diabetes insipidus and SIADH: Pathology review
Diabetes insipidus
Oxytocin and prolactin
Prader-Willi syndrome
Turner syndrome
Carpal tunnel syndrome
Parathyroid hormone
Vitamin D
Hyperparathyroidism
Hypercalcemia
Hypoparathyroidism
Hypocalcemia
Phosphate, calcium and magnesium homeostasis
Parathyroid disorders and calcium imbalance: Pathology review
Parathyroid conditions and calcium imbalance: Clinical
Chronic kidney disease
Precocious puberty
Adrenergic antagonists: Beta blockers

Transcript

Watch video only

In pheochromocytoma, pheo- means dark, chromo- refers to color, cyto- refers to a cell and -oma means tumor. So a pheochromocytoma is a rare adrenal gland tumor where the cells darken when they form tumors.

Now, there are two adrenal glands, one above each kidney, and each one has an outer layer called the cortex and an inner layer called the medulla.

In the medulla, there are cells called chromaffin cells and their job is to make hormones called catecholamines. The catecholamines include epinephrine and norepinephrine - the fight or flight hormones.

Normally, the chromaffin cells in the adrenal gland secrete epinephrine and norepinephrine into the blood when something scary happens - like someone saying BOOM!

The epinephrine and norepinephrine bind to alpha and beta receptors in various tissues throughout our body and cause an increase in cardiac output, increased blood pressure, dilated pupils, increased blood flow to skeletal muscles, and increased blood sugar.

Pheochromocytomas are tumors that form when these chromaffin cells start to divide uncontrollably.

They typically form in one of the adrenal glands, but rarely can be in both and sometimes can even develop in other parts of the body where chromaffin cells are found like the carotid arteries in the neck, the bladder, and the abdominal aorta.

Most pheochromocytomas arise sporadically, but some are associated with an inherited syndrome.

One of these is multiple endocrine neoplasias type 2A and type 2B, where pheochromocytoma is caused by a mutation in the RET gene, which is a protooncogene that encodes for proteins that promote cell growth and division.

When the RET gene mutates, it becomes an oncogene that causes the cells to divide constantly.

Another disease associated with pheochromocytomas is Von Hippel-Lindau disease, which develops when there’s a mutation in the VHL gene which codes for the von Hippel-Lindau tumor suppressor protein.

Tumor suppressor proteins normally inhibit cell growth and division and mutations result in uncontrolled cell proliferation leading to tumors.

A third disease is neurofibromatosis type 1, which is caused by a mutation in the gene NF1 that encodes for another tumor suppressor protein called neurofibromin, and the mechanism here is similar to Von Hippel-Lindau disease.

Once pheochromocytomas develop, they cause problems by releasing too many catecholamines into the blood. The catecholamine release is unregulated and could happen continuously or at random times.

However certain things like stress, physical exertion, or even certain foods that contain the molecule tyramine like chocolate, cheese, and wine can trigger the release of catecholamines.

Imagine getting stressed, and then going to the gym, and then indulging in a plate of chocolate and cheese washed down with a glass of wine - a recipe for triggering catecholamine release!

Key Takeaways

A pheochromocytoma is a neuroendocrine tumor of chromaffin cells in the adrenal medulla. Pheochromocytomas cause problems by producing too much of the catecholamines epinephrine and norepinephrine, which then causes sympathetic nervous system hyperactivity, resulting in symptoms like high blood pressure, headaches, palpitations, and sweating.

Pheochromocytomas are diagnosed by testing the urine for catecholamines and metanephrine; and imaging studies such as CT or MRI. Treatment involves surgical removal of the tumor, and medications to control blood pressure and heart rate.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?" Annals of Surgical Oncology (2007)
  7. "Multiple endocrine neoplasia type 2: An overview" Genetics in Medicine (2011)